Mason J
Preclinical and Clinical Research, Sandoz Pharma Ltd, Basle, Switzerland.
Pediatr Nephrol. 1990 Sep;4(5):554-74. doi: 10.1007/BF00869843.
Part I: The side-effects of Sandimmune that have been of most significance clinically are renal dysfunction, renal vascular damage and arterial hypertension. To examine the nature and the origin of such effects, the actions of Sandimmune on the renal tubule, the renal vessels and systemic vessels have been analyzed. To evaluate whether common vasoconstrictory systems may be involved, changes in the renin-angiotensin-aldosterone system and prostaglandin-thromboxane system have been assessed. Comparison between animal and human data obtained in vivo and in vitro shows the actions of Sandimmune on the renal tubule to be modest and involve only a few specific effects. The major action of Sandimmune is on the vessels, vasoconstriction being the major cause of renal dysfunction and also the cause of arterial hypertension. Neither the circulating renin-angiotension-aldosterone system nor the prostaglandin-thromboxane system is clearly responsible for vasoconstriction. Although not itself a vasoconstrictor, Sandimmune seems to modulate the constrictory and dilatory response to other agents in several vascular beds.
临床上最显著的环孢素副作用是肾功能障碍、肾血管损伤和动脉高血压。为了研究这些副作用的性质和起源,已对环孢素在肾小管、肾血管和全身血管上的作用进行了分析。为了评估常见的血管收缩系统是否可能参与其中,已对肾素 - 血管紧张素 - 醛固酮系统和前列腺素 - 血栓素系统的变化进行了评估。体内和体外获得的动物和人类数据的比较表明,环孢素对肾小管的作用较小,仅涉及少数特定效应。环孢素的主要作用是对血管,血管收缩是肾功能障碍的主要原因,也是动脉高血压的原因。循环中的肾素 - 血管紧张素 - 醛固酮系统和前列腺素 - 血栓素系统均与血管收缩无明显关联。尽管环孢素本身不是血管收缩剂,但它似乎能调节几种血管床对其他药物的收缩和舒张反应。